These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4019321)

  • 1. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
    Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogenic effect of bestatin on lymphocytes.
    Ishizuka M; Sato J; Sugiyama Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Jun; 33(6):653-62. PubMed ID: 7419476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.
    Watanabe Y; Tawara S; Mine Y; Kikuchi H
    J Antibiot (Tokyo); 1985 Dec; 38(12):1781-7. PubMed ID: 3005214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes.
    Rich DH; Moon BJ; Harbeson S
    J Med Chem; 1984 Apr; 27(4):417-22. PubMed ID: 6142952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The slow, tight binding of bestatin and amastatin to aminopeptidases.
    Wilkes SH; Prescott JM
    J Biol Chem; 1985 Oct; 260(24):13154-62. PubMed ID: 2865258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical identification of the cell surface bound leucine aminopeptidase, the target enzyme for the immunostimulant bestatin.
    Leyhausen G; Gramzow M; Zahn RK; Steffen R; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1983 Jun; 36(6):728-34. PubMed ID: 6348011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin.
    Leyhausen G; Schuster DK; Vaith P; Zahn RK; Umezawa H; Falke D; Müller WE
    Biochem Pharmacol; 1983 Mar; 32(6):1051-7. PubMed ID: 6838651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface aminopeptidase activity of human lymphocytes. I. Biochemical and biologic properties of intact cells.
    Amoscato AA; Alexander JW; Babcock GF
    J Immunol; 1989 Feb; 142(4):1245-52. PubMed ID: 2915119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. I. Synthesis of stereoisomeric analogues of FK-156.
    Takeno H; Okada S; Hemmi K; Aratani M; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2925-31. PubMed ID: 6518578
    [No Abstract]   [Full Text] [Related]  

  • 10. The aminopeptidase activity in the human T-cell lymphoma line (Jurkat) is not at the cell surface and is not aminopeptidase N (CD-13).
    Murray H; Turner AJ; Kenny AJ
    Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):353-60. PubMed ID: 7907864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of ubenimex on aminopeptidase activities in spleen cells and peritoneal macrophages from mice.
    Kuramochi H; Motegi A; Iwabuchi M; Takahashi K; Horinishi H; Umezawa H
    J Antibiot (Tokyo); 1987 Nov; 40(11):1605-11. PubMed ID: 3693128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W; Querido E; Crine P; DesGroseillers L
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
    Mine Y; Yokota Y; Wakai Y; Fukada S; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1983 Aug; 36(8):1045-50. PubMed ID: 6415029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain.
    Harding JW; Felix D
    Brain Res; 1987 Oct; 424(2):299-304. PubMed ID: 3676828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
    Quirk WS; Harding JW; Wright JW
    Brain Res Bull; 1987 Jul; 19(1):145-7. PubMed ID: 3651838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection.
    Mine Y; Watanabe Y; Tawara S; Yokota Y; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1983 Aug; 36(8):1059-66. PubMed ID: 6630057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells.
    Müller WE; Schuster DK; Zahn RK; Maidhof A; Leyhausen G; Falke D; Koren R; Umezawa H
    Int J Immunopharmacol; 1982; 4(5):393-400. PubMed ID: 6982243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
    Robertson MJ; Cunoosamy MP; Clark KL
    Br J Pharmacol; 1992 May; 106(1):166-72. PubMed ID: 1354540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme.
    Tieku S; Hooper NM
    Biochem Pharmacol; 1992 Nov; 44(9):1725-30. PubMed ID: 1360211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of oxytocin by the human placenta: effect of selective inhibitors.
    Mizutani S; Yokosawa H; Tomoda Y
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):76-80. PubMed ID: 1355623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.